FDA Investigator Nerizza B Guerin
Nerizza B Guerin has conducted inspections on 132 sites in 3 countries as of 24 May 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
132
Last Inspection Date:
24 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Mexico,
India
FDA Investigators that have inspected at least one site in common with Nerizza B Guerin:
Addam S Reynolds,
Adetutu M Gidado,
Alan L Truong,
Albert M Brindle,
Alberto A Viciedo,
Alice S Tsao,
Amanda B Vega,
Amy L Singer,
Amy M Cramer,
Amy Wyan Mai,
Ana P Pineda Zavaleta,
Ana S Cabrera,
Anastasia I Offordile,
Andrew O Ejiofor,
Ankur C Patel,
Ann Marie Montemurro,
Annemarie B Randow,
Annemarie Bodnar,
Antoinette L Ravelli,
Arindam Dasgupta, PhD,
Ashutosh Rao, PhD,
Atul J Agrawal,
Barbara A Burke,
Barbara D Wright,
Barbara J Maulfair,
Barbara Jwilimczyk Macri,
Bijoy Panicker,
Brandon L Mariner,
Brandy N Lepage,
Brooke K Higgins,
Brooke K Seeman,
Byungja E Marciante,
Carole L Jones,
Cary Greene,
Cassandra L Abellard,
CDR Kimberly Y Martin,
Charanjeet Jassal,
Charisse K Green,
Charles M Spyr,
Christina N Maurino,
Christopher J Adams,
Colleen F Hoyt,
Daniel J Grabicki,
David A Schwartz,
David J Eide,
David M Beltran,
David R Delucia,
Dawn C Olenjack,
Dawn L Wydner,
Denise M Visco, Investigator,
Dhaval H Patel,
Diane M Gubernot,
Diane T Bargo,
Diane T O'brien,
Dolores Harper,
Donald C Obenhuber, PhD,
Doreen P Gubbay,
Dorothy J Denes,
Douglas C Kovacs,
Dr. Jason R Caballero,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Edward O'shaughnessy,
Edwin Melendez,
Eliezar Ramos,
Emest F Bizjak,
Emily A Walters,
Emmanuel Jramos Maldonado,
Eric Rothschild,
Erma Zaimova,
Esteban Beltran,
Eufemia G Gonzalez,
Frank J Marciniak,
Frederick F Razzaghi,
Gam S Zamil,
Gary J Lehr,
Gary T Greco,
Guerlain Ulysse,
Helen B Ricalde,
Helen Verdel,
Hitesh R Patel,
Jacqueline A O'shaughnessy, PhD,
Jacqueline S Warner,
James A Liubicich,
James R Birkenstamm,
James T Mccoy,
Janet A Rajan,
Jean M Kelahan,
Jeanne D Shaffer,
Jeffrey J Ebersole,
Jennifer A Bazergui,
Jennifer L Custodio,
Jennifer Macmillan,
Jenny Sung,
Jessica M Monteiro,
Jessica S Estriplet,
Jill M Sooter,
Jill Mielziner,
Jo Annc Declement,
Jogy George,
Jonathan S Helfgott,
Jonathan W Chapman,
Jonee J Mearns,
Jose M Cayuela,
Joseph W Matthews,
Joy Rkozlowski Klena,
Juan Rjimenez Garcia,
Juanita P Versace,
Judith A Jones,
Judith A Paterson,
Justin A Boyd,
Justin H Price,
Justine Tomasso,
Kara A Scheibner, PhD,
Karen E D'orazio,
Karen F Tomaziefski,
Karen L Kosar,
Karishma G Gopaul,
Keith M Reilly,
Kelli F Dobilas,
Kelly I Anderson,
Kelly L Anderson,
Kinh Q Mac,
Kip J Hanks,
Kish Bolden,
Kristy A Zielny,
Kyle D Covill,
Lata C Mathew, PhD,
Lauren L Vajo,
Laurissa S Flowers,
Lawrence W Farina,
LCDR Anastasia M Piliafas Brown,
Leigh Anne Myers,
Lewis K Antwi,
Li Li,
Liatte Kreuger, PharmD,
Lisa B Hall,
Lisa Harlan,
Lisa Mathew,
Lisa P Oakes,
Loretta Nemchik,
Lori S Lawless,
Marcellinus D Dordunoo,
Marcelo O Mangalindan, Jr,
Marea K Harmon,
Margaret M Sands,
Margaret Torres Vazquez,
Maria Estrella,
Marion W Nadeau,
Marjorie D Schultz,
Martin K Yau, PhD,
Mayar M Mussa,
Melissa A Freeman,
Melissa B Libby,
Melissa J Garcia,
Melissa T Roy,
Meredith L Sheridan,
Merideth K Rose,
Meyer J Slobotsky,
Michael A Charles,
Michael R Klapal,
Michael Rosner,
Michael Serrano,
Michelle M Parisi,
Mohsen Rajabi Abhari, FDA,
Myra K Casey,
Nancy F Scheraga,
Nancy M Espinal,
Nazmul Hassan,
Neil J Bonzagni, PhD MPH,
Nerizza B Dalena,
Nicholas A Violand,
Niketa Patel,
Nikisha M Bolden,
Nina D Patel,
Nina Yang,
Patricia A Morrow,
Patrick C Klotzbuecher,
Paul L Bellamy,
Peter R Lenahan,
Philip F Istafanos, DMV, MS,
Rachel C Harrington,
Rafael Nevarez Nieves,
Randolph Campos Santiago,
Raymond L Cheung,
Rebecca Rodriguez,
Regina T Brown,
Richard D Manney,
Richard J Bashay,
Robert C Steyert,
Robin P Mathew,
Rose Ashley,
Rose Ljean Mary,
Russell J Glapion,
Russell P Vandermark,
Samina S Khan,
Samir C Gala,
Sarah Forney,
Satheesh K Podaralla,
Satheesh Thomas,
Schultz,
Sean G Casey,
Seng Ching Hwang,
Sharon Ferraro,
Sharon K Thoma, PharmD,
Sherri J Liu,
Shirley H Isbill,
Shirley S Wen,
Shirshendu K Deb, PhD,
Shusheen A Alexander,
Sinai I Davis,
Sony Mathews,
Stephanie Mangigian, MS/OSH, RN,
Stephanie T Durso,
Stephen D Brown,
Stephen J Mottola,
Stephenie M Ortiz,
Steven M Weinman,
Steven P Donald,
Suchan Kim,
Susan M Halsted,
Susan M Joseph,
Susan T Hadman,
Suzanne M Healy,
Suzanne M Muchene,
Tajah L Blackburn,
Tanya R Syffrard,
Tara G Bizjak,
Tara R Gooen,
Tawny L Colling,
Terry Bridgewater,
Thomas J Mooney,
Tonia F Bernard,
Tressa T Lewis,
Tyanna N Hadley,
Uduak M Inokon,
Valerie C Reed,
Valerie Reed,
Victoria Spivak,
Vipulchandra N Dholakia,
Wanda Y Fields,
Wanda Y Honeyblue,
Wayne J Meyer,
William J Leonard,
William J Muszynski,
William R Brubaker,
William W Dotts,
Xiaohan Cai, PhD
Nerizza B Guerin's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more